NovaBridge Biosciences: eps_basic
| Value | {"per": "shares", "amount": -28.9, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/21ab2864-7019-4968-a728-bc73cdb30c2d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-20-124785Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/eps-basic/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/21ab2864-7019-4968-a728-bc73cdb30c2d
History
- supersedes {"per": "shares", "amount": -201.19, "concept": "us-gaap:EarningsPerShareBasic", "currency": "CNY"} (evidence 0001193125-20-124785)